|
Study of Patients with Strongyloides stercoralis Infection Clinical Trials Information presented on Clinical Trials Search isn't designed to be a substitute for certified healthcare advice, travels to or professional assistance using a genuine medical doctor. We are not physicians. Always confer with your dr. about Study of Patients with Strongyloides stercoralis Infection conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Study of Patients with Strongyloides stercoralis Infection Clinical research trials and Study of Patients with Strongyloides stercoralis Infection medical trials happen in hundreds of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually measure the effectualness of new drugs. The intention of the studies / undertakings is to solve certain human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all forms of circumstances, such as Study of Patients with Strongyloides stercoralis Infection. Study of Patients with Strongyloides stercoralis Infection Clinical Trials and other clinical trials allow for volunteers to undergo medical treatment choices before they are available to the general public. Some times the human subjects get treatment for free of charge, and sometimes they are paid for their time. Occasionally there is a cost for a Study of Patients with Strongyloides stercoralis Infection clinical trial. Participants frequently get the best healthcare available for their Study of Patients with Strongyloides stercoralis Infection condition. Risks are a reality, nonetheless, and can include extra or frequent physician trips, medical risks (possibly life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with exacting guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "S" Clinical Trials Conditions > Study of Patients with Strongyloides stercoralis Infection  Study of Patients with Strongyloides stercoralis Infection
Study of Patients with Strongyloides stercoralis Infection
For Condition: HIV Infection,Nematode Infection,Strongyloidiasis
Status: Recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: This study will explore faster and easier ways to detect infection with the intestinal parasite Strongyloides stercoralis and learn more about the conditions under which it causes serious disease. Ordinarily, the Strongyloides helminth (type of intestinal worm) causes only few, if any, symptoms, but in people with weakened immunity it may be very serious, and even deadly. People between 5 and 80 years of age with known or suspected S. stercoralis infection, or infection with another helminth, such as filariasis, that might cause a cross-reaction with S. stercoralis may be eligible for this study. Participants found to be infected with S. stercoralis will be treated with ivermectin, thiabendazole, or albendazole. In addition, they will undergo the following tests and procedures: - Blood tests and stool samples: Samples will be collected before and after treatment to check general health status and immune function, and to look for parasites in stool. Up to 50 milliliters (10 teaspoons) of blood will be drawn in adults and up to 25 ml (5 teaspoons) in children. - Skin tests: A test similar to those used for tuberculosis and allergies will be conducted to determine if there is sensitization to products of the parasite. Such a test might be used as a rapid method to diagnose the infection. About three drops of several different antigens (proteins) are injected into the skin of the arm. After 15 to 20 minutes, the area is checked to see if a red spot has formed and, if so, the spot is measured.
Details: This study is directed to patients with known or suspected Strongyloides stercoralis infection because it is a relatively common parasitic infection, even in the United States; it is difficult to diagnose, and efficacy of treatment is difficult to evaluate. Some infected individuals can develop serious, even fatal, disease under certain conditions of immunosuppression. We have developed an immediate hypersensitivity skin test which appears useful for more rapid and simplified diagnosis of infection with the parasite. A cDNA library from the infective form of the parasite has been prepared, and several clones identified from which we will try to select recombinant gene products that can be used as diagnostic antigens. An interesting association of infection with the strongyloides parasite in certain patients also infected with the retrovirus HTLV-1 has been discovered, in which activation of Th1 cytokines and output of interferon gamma results in lowering of serum IgE. This can lead to greater likelihood of severe disease in some patients or incomplete response to treatment.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: INCLUSION CRITERIA: Age of 5 to 80 years and of either sex. Parents or guardian for children under 18 years must be able to understand and sign informed consent. Presence of known or suspected infection with Stronglyloides stercoralis, such as significant peripheral blood eosinophilia (greater than 1000 eosinophils/mm(3)) for which no other cause is apparent. EXCLUSION CRITERIA: None, other than those conditions which fail to meet hte inclusion criteria listed above. Pregnancy is not a criteria for exclusion.
Total Enrollment: 650
Location and Contact Information:
National Institute of Allergy and Infectious Diseases (NIAID) *Recruiting*
Bethesda, Maryland, 20892
United States
Recruiting Patient and Public Liaison Office 1-800-411-1222
Additional Information:
Study ID Numbers: 890174; 89-I-0174
Study Start Date: August 25, 1989
Record last reviewed: August 28, 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001245
Other Strongyloidiasis Studies:
1. Study of Patients with Strongyloides stercoralis Infection
Related Studies:
Other Strongyloidiasis Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Study of Patients with Strongyloides stercoralis Infection
|
|
|
|
|
|
|
|
